Russell Investments Group, Ltd. Alaunos Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$2.63 - $3.67 $206,668 - $288,392	-78,581 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$2.82 - $5.6 $221,598 - $440,053	78,581 New	78,581 $282,000
Q4 2020 Feb 08, 2021	SELL	$2.09 - $3.09 $173,760 - $256,899	-83,139 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$2.39 - $3.43 $135,317 - $194,199	56,618 Added 213.48%	83,139 $209,000
Q3 2019 Nov 01, 2019	BUY	$4.13 - $6.94 $109,531 - $184,055	26,521 New	26,521 $114,000
Q1 2019 May 13, 2019	SELL	$2.0 - $4.4 $258,090 - $567,798	-129,045 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$1.61 - $3.62 $38,631 - $86,861	-23,995 Reduced 15.68%	129,045 $241,000
Q3 2018 Oct 26, 2018	SELL	$2.26 - $3.27 $179,247 - $259,353	-79,313 Reduced 34.13%	153,040 $490,000
Q1 2018 May 11, 2018	BUY	$3.46 - $5.14 $803,941 - $1.19 Million	232,353 New	232,353 $911,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.